Treatment of Early AIDS Dementia in Intravenous Drug Users: High Versus Low Dose Peptide T

References

• Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I. Clinical features. Ann. Neurol. 1986; 19: 517–524
   PubMed Web of Science ®Google Scholar
• Navia B. A., Cho E., Peptito C. K., et al. The AIDS dementia complex: II. Neuropathology. Ann. Neurol. 1986; 19: 525–535
   PubMed Web of Science ®Google Scholar
• Price R. W., Brew B., Sidtis J. The brain in AIDS: Central nervous system HIV-I infection and AIDS dementia complex. Science 1988; 89: 586–592
   Google Scholar
• Price R. W., Brew B. J. The AIDS dementia complex. J. Infect. Dis. 1989; 158: 1079–1083
   Web of Science ®Google Scholar
• Bridge T. P. HIV-1: Neuropsychiatric manifestations and their treatment, Psychopharmacol. Bull. 1988; 23: 320–324
   Google Scholar
• Wiley C. A., Schrier R. D., Nelson J. A., et al. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency patients. Proc. Natl. Acad. Sci. USA 1986; 83: 7089–7093
   PubMed Web of Science ®Google Scholar
• Bridge T. P., Heseltine P. N., Parker E. S. Improvement in AIDS patients on Peptide T. Lancet 1989; 1: 226–227
   Google Scholar
• Bridge T. P., Heseltine P. N., Parker E. S., et al. Results of extended Peptide T administration in AIDS and ARC patients. Psychopharmacol. Bull. 1991; 27: 237–245
   PubMed Web of Science ®Google Scholar
• Bridge T. P., Linde R., Olio C, et al. Neuropsychologic results of control HIV-1 trial of Peptide T. Seventh International Conference on AIDS. 1991. FlorenceItaly June, 1991
   Google Scholar
• Rosen M. I., Bridge T. P., O'Malley S. S., et al. Peptide T treatment of cognitive impairment in HIV seropositive intravenous drug users. Am. J. Addict. 1992; 1: 1–7
   Google Scholar
• Schmitt F. A., Bigley J. W., McKinnis R., et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 1988; 319: 1573–1578
   PubMed Web of Science ®Google Scholar
• Portegies P., DeGans J., Lange J. M., et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. B.M.J. 1989; 299: 819–821
   PubMed Web of Science ®Google Scholar
• Yarochan R., Thomas R. V., Grafman J., et al. Long-term administration of 3′-zido-2′3′-dideoxythymidine to patients with AIDS-related neurological disease. Ann. Neurol. 1988; 23: S82–S87
   PubMed Web of Science ®Google Scholar
• Elovaara I., Poutianinen E., Lahdevirta J., Hokkanen L. Zidovudine reduces intrathecal immoactivation in patients with early human immunodeficiency virus type I infection. Finland Arch. Neurology 1994; 51: 943–950
   PubMedGoogle Scholar
• Karlsen N. R., Reinvang I., Froland S. S. A follow-up study of neuropsychological functioning in AIDS-patients: Prognostic significance and effect of zidovudine therapy. Acta Neurologica Scandinavica 1995; 91: 215–221
   PubMed Web of Science ®Google Scholar
• Wechsler D. Wechsler Adult Intelligence Scale-Revised. Psychological Corporation, New York 1981
   Google Scholar
• Dunn L. M., Markwardt F. C. PIAT: Peabody Individual Achievement Test. American Guidance Service, Circle Pines, Minnesota 1970
   Google Scholar
• Reitan R. M., Wolfson D. The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Neuropsychology Press, Tucson, Arizona 1985
   Google Scholar
• Lezak M. D. Neuropsychological Assessment. Oxford University Press, New York 1983
   Google Scholar
• Lafayette Instrument Company. Instructions for the Grooved Pegboard Test. Lafayette Instrument Company, LafayetteIndiana 1989
   Google Scholar
• Golden C. J. The Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Stoelting Company, Chicago, Illinois 1978
   Google Scholar
• Levin H. S., Mattis S., Ruff R. M., et al. Neurobehavioral outcome following minor head injury: A three center study. J. Neurosurgery 1987; 66: 234–243
   PubMed Web of Science ®Google Scholar
• Gronwall D. Paced auditory serial addition task: A measure of recovery from concussion. Percept. Mot. Skills 1977; 44: 367–373
   PubMed Web of Science ®Google Scholar
• Roman D. D., Edwall G. E., Buchman R. J., et al. Extended norms for the Paced Auditory Serial Addition Task. Clin. Neuropsychologist 1991; 5: 33–40
   Google Scholar
• Ingraham L. J., Bridge T. P. An empirical approach to determining criteria for abnormality in test batteries with multiple measures. Neuropsychology 1996; 10: 120–124
   Web of Science ®Google Scholar
• Benton A. L., Hamsher K. D. Multilingual Aphasia ExaminationSecond Edition. University of Iowa, Iowa City 1976
   Google Scholar
• Yeudall L. T., Fromm D., Reddon J. R., et al. Normative data stratified by age and sex for 12 neuropsychological tests. J. Consult. Clin. Psychology 1986; 42: 918–946
   Google Scholar
• Heaton R. K., Grant I., Matthews C. G. Comprehensive Norms for an Extended. Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Psychological Assessment Resources, Odessa, Florida 1991
   Google Scholar
• Parker E. S., Bridge T., Ingraham L., et al. Neurotoxicity battery for phase I HIV drug assessment: Initial applications. Int. Conf. AIDS 1989; 5(2)462
   Google Scholar
• Lewis R. F., Rennick P. M. Manual for the Repeatable Cognitive Perceptual-Motor Battery. Axon Publishing, Grosse Pointe Park, Mississippi 1979
   Google Scholar
• Siberstein C. H., O'Dowd M. A., Chartock P., et al. A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients. Gen. Hosp. Psychiatry 1993; 15: 351–359
   PubMed Web of Science ®Google Scholar
• Egan V., Brettle R. P., Goodwin G. M. The Edinburgh cohort of HIV-positive drug users: Patterns of cognitive impairment in relation to progression of disease. British J. Psychiatry 1992; 161: 522–531
   PubMed Web of Science ®Google Scholar
• McKegney F. P., O'Dowd M. A., Feiner C, et al. A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS 1990; 4: 565–569
   PubMed Web of Science ®Google Scholar
• Heaton R. K., Grant I., Butters N., et al. The HNRC 500: Neuropsychology of HIV infection at different disease stages. J. Int. Neuropsychological Society 1995; 1: 231–251
   PubMedGoogle Scholar
• Beason-Hazen S., Nasrallah H. A., Bornstein R. A. Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. J. Neuropsychiatry Clin. Neurosciences 1994; 6: 43–49
   PubMed Web of Science ®Google Scholar
• van Gorp W. G., Hinkin C, Satz P., et al. Subtypes of HIV-related neuropsychological functioning: A cluster analysis approach. Neuropsychology 1993; 7: 62–72
   Google Scholar
• van Dyck C. H., McMahon T. J., Rosen M. I., et al. Sustained-release methylphenidate for cognitive impairment in HIV-infected drug abusers: A pilot study. J. Neuropsychiatry Clin. Neurosciences, in press
   Web of Science ®Google Scholar
• Peterson P. K., Sharp B. M., Gekker G., et al. Opiates, human peripheral blood mononuclear cells, and HIV. Advances in Experimental Medicine Biology 1991; 288: 171–178
   PubMedGoogle Scholar